EAM
BSX icon

Exane Asset Management’s Boston Scientific BSX Stock Holding History

Exane Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-89,197
Closed -$6.45M – 31
2026
Q1 		$6.45M Buy
+89,197
New +$7.14M 1.32% 18
2025
Q4 		– Sell
-79,463
Closed -$9.12M – 37
2025
Q3 		$9.12M Buy
+79,463
New +$8.23M 3.07% 9

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Exane Asset Management's BSX Position: Q2 2026 in Review

Exane Asset Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 89,197 shares — an estimated $6.45M sold.

Exane Asset Management first reported a position in BSX in Q3 2025 and held it in 2 quarters. The position peaked at $9.12M in Q3 2025. 174 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Exane Asset Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Exane Asset Management sold 89,197 Boston Scientific shares in Q2 2026, an estimated $6.45M.
  • Exane Asset Management first reported a position in Boston Scientific in Q3 2025 and held it in 2 quarters.
  • Exane Asset Management's Boston Scientific position peaked at $9.12M in Q3 2025.
  • 174 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Exane Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.